Lipoprotein(a) and coronary disease—moving closer to causality
- 1 September 2009
- journal article
- Published by Springer Science and Business Media LLC in Nature Reviews Cardiology
- Vol. 6 (9), 565-567
- https://doi.org/10.1038/nrcardio.2009.138
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJama-Journal Of The American Medical Association, 2009
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial InfarctionJAMA, 2009
- Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery diseaseNature Genetics, 2009
- Lipoprotein(a) Levels and Risk of Future Coronary Heart DiseaseLarge-Scale Prospective DataArchives of Internal Medicine, 2008
- New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A 2 in Atherosclerosis and Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Lipoprotein(a): A Unique Risk Factor for Cardiovascular DiseaseClinics in Laboratory Medicine, 2006
- Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization’International Journal of Epidemiology, 2006
- Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future DirectionsClinical Chemistry, 2003
- Has Lipoprotein 'Little' (a) Shrunk?JAMA, 1993
- A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEMActa Pathologica Microbiologica Scandinavica, 1963